Citation 105262

AGULLO,G: GAMET-PAYRASTRE,G: MANENTI,S: VIALA,C: REMESY,C: CHAP,H: PAYRASTRE,B:. (1997). RELATIONSHIP BETWEEN FLAVONOID STRUCTURE AND INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE: A COMPARISON WITH TYROSINE KINASE AND PROTEIN KINASE C INHIBITION.. 53(11)

Citation Details

Title	RELATIONSHIP BETWEEN FLAVONOID STRUCTURE AND INHIBITION OF PHOSPHATIDYLINOSITOL 3-KINASE: A COMPARISON WITH TYROSINE KINASE AND PROTEIN KINASE C INHIBITION.
Authors	AGULLO,G: GAMET-PAYRASTRE,G: MANENTI,S: VIALA,C: REMESY,C: CHAP,H: PAYRASTRE,B:
Year	1997
Volume	53
Issue	11

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CHRYSIN	INACTIVE
2	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
3	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHRYSIN	INACTIVE
4	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	APIGENIN	ACTIVE
5	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
6	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
7	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	LUTEOLIN	ACTIVE
8	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	INACTIVE
9	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
10	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	DIOSMETIN	INACTIVE
11	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	WEAK ACTIVITY
12	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSMETIN	ACTIVE
13	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	GALANGIN	INACTIVE
14	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE
15	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALANGIN	INACTIVE
16	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	KAEMPFEROL	INACTIVE
17	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
18	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
19	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	QUERCETIN	ACTIVE
20	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
21	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
22	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	FISETIN	INACTIVE
23	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE
24	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE
25	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MORIN	INACTIVE
26	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
27	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
28	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	MYRICETIN	ACTIVE
29	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	WEAK ACTIVITY
30	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
31	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	CATECHIN,(+):	INACTIVE
32	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
33	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
34	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	HESPERETIN	INACTIVE
35	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
36	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HESPERETIN	INACTIVE
37	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	GENISTEIN	INACTIVE
38	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
39	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	INACTIVE
40	PHOSPHATIDYLINOSITOL KINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	TAXIFOLIN	INACTIVE
41	EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE
42	PHOSPHOKINASE C INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXIFOLIN	INACTIVE

Citation 105262

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1